The pandemic proved drug development can move faster. Now 82% of FDA submissions include RWE, but data harmonization and traceability remain key hurdles. Pharma can overcome this by "starting with the end in mind." Read how in @MedCityNews
:
HEALTHCARE AI
-
FDA RWE Submissions Accelerate Pharma Drug Development Process
By
–
-
Prompt Ensembling Beats Single Prompts for High-Impact Decisions
By
–
When prompt ensembling beats single prompts: High-stakes business decisions ($100K+ impact) Medical/legal advice (where errors cost lives/money) Creative work (logo design, brand names, campaign ideas) Strategic planning (5-year roadmaps, market entry) Code
-
Neuralink Blindsight Device Promises Vision Restoration for Blind
By
–
C'est complètement dingue….
— VISION IA (@vision_ia) 29 janvier 2026
ELON MUSK : « Notre prochain produit, Blindsight, permettra à des personnes ayant une perte totale de vision, y compris celles qui ont perdu leurs yeux ou le nerf optique, ou qui n’ont peut-être jamais vu, voire qui sont aveugles de naissance, de… pic.twitter.com/t50o5kuLPvIt's completely insane…. ELON MUSK: "Our next product, Blindsight, will allow people with total vision loss, including those who have lost their eyes or optic nerve, or who may have never seen, or even those blind from birth, to regain their sight." I never thought I'd see
-

Microsurgery Robot Demonstrates Millimeter-Level Precision Achievement
By
–
This one really stopped me in my tracks. A microsurgery robot just stitched up a corn kernel. Not as a gimmick, but as a proof of millimeter-level precision. Think about what that means:
→ Movements smaller than a grain of rice
→ Perfect stability with no hand tremor
→ -

AlphaGenome Advanced Genomics Model Published in Nature
By
–
AlphaGenome is our latest & most advanced genomics model published in @Nature today including making the model & weights available to academic researchers. Can’t wait to see what the research community will do with it. Congrats to the team on our newest front cover! #AI4Science
-

AI Disempowerment Risk in Healthcare and Relationships Contexts
By
–
Disempowerment potential appeared most often in conversations about relationships & lifestyle or healthcare & wellness—topics where users are most personally invested. Technical domains like software development, which make up ~40% of usage, carried minimal risk.
-
Clinical Trust in AI: Evidence, Evaluation, and Transparency Requirements
By
–
Forbes gathers perspectives from health leaders on alignment, transparency, and responsible tech to reduce healthcare costs.
— Catherine Adenle (@CatherineAdenle) 28 janvier 2026
It includes a contribution from Elsevier’s Jan Herzhoff on why clinicians' trust in AI requires evidence-based tools, regular evaluation, and transparent… pic.twitter.com/uPgWANJVpiForbes gathers perspectives from health leaders on alignment, transparency, and responsible tech to reduce healthcare costs.
It includes a contribution from Elsevier’s Jan Herzhoff on why clinicians' trust in AI requires evidence-based tools, regular evaluation, and transparent -
Best Healthcare AI Tools: AlphaFold and AI CoScientist Guide
By
–
List all the best tools for healthcare, alphafold, ai coscientist ? what's your best tools list ? then create skills, and ask for a goal
-

SAS AI Strengthens Patient Care at Erasmus MC Hospital
By
–
With SAS, Erasmus MC is strengthening human connection in patient care while trusting technology to support safer, more informed clinical decisions. Helping teams confidently treat patients and the technology behind them. More about the lab http://
2.sas.com/6010CFdpp #DataForGood -
India-EU Trade Deal: Pharma IP Collaboration Benefits
By
–
Youngsuk ‘YS’ Chi, Chairman of Elsevier, highlighted the benefits of the India-EU trade deal collaboration, stating, “I think the businesses will benefit by making sure that we collaborate on ….” https://
bit.ly/4a5p41P
#health #Pharma #intellectualproperty